Literature DB >> 417457

Morphogenesis and significance of fibrous bodies in human pituitary adenomas.

E Horvath, K Kovacs.   

Abstract

In the course of light and electron microscopic studies of 142 surgically-removed human pituitary adenomas, 28 tumors were found containing fibrous bodies composed of type II microfilaments with an average width of 115A. These spherical structures, measuring up to 4-5 micrometer occur exclusively in sparsely granulated growth hormone cells and acidophil stem cells, but as revealed by the immunoperoxidase technique, contain no growth hormone. Fibrous bodies are located in the Golgi region and are consistently associated with Golgi membranes and smooth-surfaced endoplasmic reticulum. Their association with centrioles is thought to be anatomical rather than functional. Several adenoma cells possess spherical formations composed entirely of smooth-walled membranes or transitional forms between smooth tubules and type II microfilaments, suggesting that smooth membranes may play a key role in the production of fibrillar substance. Fibrous bodies appear to be reliable morphologic markers and are valuable in the differential diagnosis of pituitary adenomas.

Entities:  

Mesh:

Year:  1978        PMID: 417457     DOI: 10.1007/bf02888984

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol


  20 in total

1.  Unusual type of growth hormone-producing pituitary tumor in acromegaly.

Authors:  Satoshi Yamagata; Kazunori Kageyama; Satoru Sakihara; Shozo Yamada; Shinobu Takayasu; Shinji Chikazawa; Naoko Inoshita; Toshiaki Sano; Toshihiro Suda
Journal:  Endocr Pathol       Date:  2012-09       Impact factor: 3.943

2.  Immunocytochemical demonstration of intermediate filament cytoskeleton proteins in human endocrine tissues and (neuro-) endocrine tumours.

Authors:  H Hoefler; H Denk; E Lackinger; G Helleis; J M Polak; P U Heitz
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

3.  Immunolocalisation of cytokeratins in the normal and neoplastic human pituitary gland.

Authors:  J W Ironside; J A Royds; A A Jefferson; W R Timperley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-01       Impact factor: 10.154

4.  Cytokeratin distribution and functional properties of growth hormone-producing pituitary adenomas.

Authors:  Toshiaki Sano; Shozo Yamada; Takashi Hi Rose; Kazuo Hizawa
Journal:  Endocr Pathol       Date:  1994-06       Impact factor: 3.943

5.  Bronchial carcinoid with paranuclear fibrillary inclusions related to cytokeratins and vimentin.

Authors:  M Barbareschi; B Frigo; S Cristina; L Valentini; E Leonardi; L Mosca
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

6.  Cytoarchitectural analysis of epithelial sheets formed in vitro by hepatic tumor cells possessing defined intermediate-sized filament cytoskeletal abnormalities.

Authors:  M P Ryan; E Borenfreund; P J Higgins
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

7.  Morphological and biochemical relationships in 31 human pituitary adenomas with acromegaly.

Authors:  J Trouillas; C Girod; M Lhéritier; B Claustrat; M P Dubois
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

8.  Expression of adhesion molecules and cytokeratin 20 in merkel cell carcinomas.

Authors:  Yasushi Tanaka; Toshiaki Sano; Zhi Rong Qian; Mitsuyoshi Hirokawa
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

9.  Immunohistochemical localization of keratin in craniopharyngiomas and squamous cell nests of the human pituitary.

Authors:  S L Asa; K Kovacs; J M Bilbao; G Penz
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

10.  Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form.

Authors:  Abdulkader Obari; Toshiaki Sano; Kenichi Ohyama; Eiji Kudo; Zhi Rong Qian; Akiko Yoneda; Nasim Rayhan; Muhammad Mustafizur Rahman; Shozo Yamada
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.